You have 9 free searches left this month | for more free features.

glucagon-like peptide-1 (GLP-1)

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Enterovirus Infections, Influenza Trial in Hangzhou (EV71 vaccine and influenza vaccine, EV71 vaccine, influenza vaccine)

Completed
  • Enterovirus Infections
  • Influenza
  • EV71 vaccine and influenza vaccine
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang provincial center for disease control and prevention
Oct 10, 2022

Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10

Completed
  • Malignant Solid Tumor
  • Metastatic EphA2 Positive Cancer
  • DS-8895a 1 mg/kg
  • +2 more
  • Heidelberg, Victoria, Australia
    Austin Health
Oct 3, 2022

Type 1 Diabetes Trial in La Jolla (Acetazolamide)

Not yet recruiting
  • Type 1 Diabetes
  • La Jolla, California
    UC San Diego Altman Clinical & Translational Research Institute
Jul 26, 2022

MDD, Treatment Resistant Depression, Smoking Cessation Trial in Baltimore (Dextromethorphan)

Completed
  • MDD
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins Department of Psychiatry
Jan 7, 2022

Covid19, SARS-CoV Infection, Coronavirus Infection Trial in Baltimore (Camostat Mesilate, Bicalutamide 150 mg)

Terminated
  • Covid19
  • +2 more
  • Camostat Mesilate
  • Bicalutamide 150 mg
  • Baltimore, Maryland
    Johns Hopkins Hospital
Sep 15, 2021

Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Warsaw, Mazowieckie, Poland
  • +1 more
Jun 8, 2023

Fatigue Trial in Giza (Fatigue protocol (repeated sprint ability), Sham Comparator: Control group)

Completed
  • Fatigue
  • Fatigue protocol (repeated sprint ability)
  • Sham Comparator: Control group
  • Giza, Egypt
    Cairo University
Oct 4, 2023

Breast Cancer Trial in Lisboa (Aerobic Training Group, Resistance Training Group, Control group)

Not yet recruiting
  • Breast Cancer
  • Aerobic Training Group
  • +2 more
  • Lisboa, Portugal
    Fundação Champalimaud
Jul 25, 2022

Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Boston (AGEN1423,

Not yet recruiting
  • Advanced Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 18, 2022

Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

Not yet recruiting
  • Polycythemia; Familial
  • +5 more
  • (no location specified)
Feb 2, 2022

Registration of Sepsis Patients in the Emergency Department

Not yet recruiting
  • Sepsis
  • no intervention
  • (no location specified)
Sep 28, 2023

Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension Trial (BP Threshold for medication initiation)

Not yet recruiting
  • Hypertensive Disorder of Pregnancy
  • +10 more
  • BP Threshold for medication initiation
  • (no location specified)
Sep 28, 2023

The Lived Experience of People With Von Willebrand Disease

Not yet recruiting
  • Von Willebrand Diseases
  • Online Survey
  • +2 more
  • (no location specified)
Oct 3, 2023

Activity, Motor, Social Isolation Trial in Pittsburgh (Social Incentive, Standard Incentive)

Completed
  • Activity, Motor
  • Social Isolation
  • Social Incentive
  • Standard Incentive
  • Pittsburgh, Pennsylvania
    Carnegie Mellon University
Jan 5, 2022

Pulpitis - Irreversible Trial in New Delhi (Lidocaine Hydrochloride)

Completed
  • Pulpitis - Irreversible
  • Lidocaine Hydrochloride
  • New Delhi, India
    Faculty of Dentistry, Jamia MIliia Islamia
May 4, 2022

Erectile Dysfunction Trial in Thessaloniki (Dornier Aries2 device, Dornier Aries2 device (sham probe))

Completed
  • Erectile Dysfunction
  • Dornier Aries2 device
  • Dornier Aries2 device (sham probe)
  • Thessaloniki, Greece
    G.Gennimatas Hospital
May 4, 2022

Atherosclerotic Cardiovascular Disease in Brazilian Population

Recruiting
  • Cardiovascular Diseases
  • +4 more
  • Exposure to genetics (polygenic)
  • Rio Branco, AC, Brazil
  • +40 more
Aug 23, 2022

HIV Trial in Boston (Teduglutide, Placebo)

Completed
  • HIV
  • Boston, Massachusetts
    Massachusetts General Hospital
May 26, 2021

Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Obesity, Diabetes Type 2 Trial in Lancaster (Semaglutide Pen Injector [Ozempic])

Recruiting
  • Obesity
  • Diabetes Type 2
  • Semaglutide Pen Injector [Ozempic]
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jul 29, 2022

Alcoholism, Substance-related Disorders, Dual Diagnosis Trial in Charleston (Combined Recovery Program, Stable & Able (S&A))

Not yet recruiting
  • Alcoholism
  • +2 more
  • Combined Recovery Program
  • Stable & Able (S&A)
  • Charleston, South Carolina
    Ralph H. Johnson VA Medical Center, Charleston, SC
Jul 29, 2022

COVID-19 Trial in Washington, Baltimore (Belnacasan, Placebo)

Recruiting
  • COVID-19
  • Washington, District of Columbia
  • +1 more
May 12, 2022

Tinea Cruris, Tinea Pedis Trial in United States (UHE-103 Cream, Naftin (naftifine HCl) Cream)

Recruiting
  • Tinea Cruris
  • Tinea Pedis
  • UHE-103 Cream
  • Naftin (naftifine hydrochloride) Cream
  • San Diego, California
  • +4 more
May 2, 2022

Aortic Valve-sparing Root Replacement, According to Inclusion

Recruiting
  • Aortic Root Aneurysm
  • Aortic Regurgitation
  • No intervention
  • Nantes, France
    Nantes University Hospital
Aug 23, 2022

Special Drug Use-results Surveillance of Tabrecta Tablets

Recruiting
  • Non-small Cell Lung Cancer
  • Tabrecta tablets
  • Nagoya, Aichi, Japan
  • +44 more
Aug 1, 2022